Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.35 USD
Change Today -0.10 / -0.69%
Volume 563.0K
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Julian Adams Ph.D.

President of Research & Development, Infinity Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 24 board members in 3 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Julian Adams, Ph.D. has been the President of Research & Development at Infinity Pharmaceuticals, Inc. since October 2007. Dr. Adams served the Chief Scientific Officer and Senior Vice President of Research & Development at Infinity Pharmaceuticals Inc. since October 2003. From December 1999 to October 2003, Dr. Adams served as a Senior Vice President of Drug Discovery & Development at Millennium Pharmaceuticals. He joined Millennium Pharmaceuticals in December of ...

Read Full Background

Corporate Headquarters*

780 Memorial Drive
Cambridge, Massachusetts 02139

United States

Phone: 617-453-1000
Fax: 617-453-1001

Board Members Memberships*

Former Director
Former Director and Member of Nominating & Governance Committee


Massachusetts Institute of Technology
McGill University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$465,800

Stock Options*

All Other Compensation$1,806
Exercisable Options743,728
Exercisable Options Value$3,332,299
Unexercisable Options166,312
Unexercisable Options Value$581,903
Total Value of Options$3,914,202
Total Number of Options910,040

Total Compensation*

Total Annual Cash Compensation$467,606
Total Short Term Compensation$465,800
Other Long Term Compensation$1,806
Total Calculated Compensation$2,651,306
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INFI:US $14.35 USD -0.10


Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
Amr Mamdouh Abdel Majid Chairman of the Board and Managing Director
GlaxoSmithKline S.A.E
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INFINITY PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at